| Target Price | $183.60 |
| Price | $172.05 |
| Potential | 6.71% |
| Number of Estimates | 20 |
| 20 Analysts have issued a price target 3M 2026 . The average 3M target price is $183.60. This is 6.71% higher than the current stock price. The highest price target is $208.95 21.45% , the lowest is $110.60 35.72% . | |
| A rating was issued by 24 analysts: 15 Analysts recommend 3M to buy, 8 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the 3M stock has an average upside potential 2026 of 6.71% . Most analysts recommend the 3M stock at Purchase. |
22 Analysts have issued a sales forecast 3M 2025 . The average 3M sales estimate is $24.5b . This is 1.23% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $25.7b 3.40% , the lowest is $23.7b 4.48% .
This results in the following potential growth metrics:
| 2024 | $24.6b | 0.14% |
|---|---|---|
| 2025 | $24.5b | 0.22% |
| 2026 | $25.3b | 3.23% |
| 2027 | $26.0b | 2.85% |
| 2028 | $27.3b | 4.85% |
| 2029 | $28.6b | 4.92% |
20 Analysts have issued an 3M EBITDA forecast 2025. The average 3M EBITDA estimate is $6.9b . This is 9.25% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.4b 17.55% , the lowest is $6.5b 2.76% .
This results in the following potential growth metrics and future EBITDA Margins:
| 2024 | $6.4b | 3.16% |
|---|---|---|
| 2025 | $6.9b | 8.22% |
| 2026 | $7.3b | 5.55% |
| 2027 | $7.8b | 6.94% |
| 2028 | $8.1b | 3.80% |
| 2029 | $8.5b | 4.65% |
| 2024 | 25.93% | 3.30% |
|---|---|---|
| 2025 | 28.12% | 8.45% |
| 2026 | 28.76% | 2.28% |
| 2027 | 29.90% | 3.96% |
| 2028 | 29.60% | 1.00% |
21 3M Analysts have issued a net profit forecast 2025. The average 3M net profit estimate is $4.3b . This is 26.88% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.5b 33.17% , the lowest is $4.2b 22.40% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | $4.2b | 159.66% |
|---|---|---|
| 2025 | $4.3b | 3.41% |
| 2026 | $4.6b | 7.45% |
| 2027 | $5.0b | 8.40% |
| 2028 | $5.3b | 6.43% |
| 2029 | $5.4b | 0.20% |
| 2024 | 16.98% | 159.74% |
|---|---|---|
| 2025 | 17.60% | 3.65% |
| 2026 | 18.32% | 4.09% |
| 2027 | 19.31% | 5.40% |
| 2028 | 19.60% | 1.50% |
21 Analysts have issued a 3M forecast for earnings per share. The average 3M EPS is $8.12 . This is 28.48% higher than earnings per share in the financial year 2024. The highest EPS forecast is $8.53 34.97% , the lowest is $7.84 24.05% .
This results in the following potential growth metrics and future valuations:
| 2024 | $7.55 | 159.83% |
|---|---|---|
| 2025 | $8.12 | 7.55% |
| 2026 | $8.73 | 7.51% |
| 2027 | $9.46 | 8.36% |
| 2028 | $10.07 | 6.45% |
| 2029 | $10.09 | 0.20% |
| Current | 27.22 | 68.32% |
|---|---|---|
| 2025 | 21.18 | 22.20% |
| 2026 | 19.71 | 6.94% |
| 2027 | 18.18 | 7.76% |
| 2028 | 17.09 | 6.00% |
| 2029 | 17.05 | 0.23% |
Based on analysts' sales estimates for 2025, the 3M stock is valued at an EV/Sales of 4.03 and an P/S ratio of 3.73 .
This results in the following potential growth metrics and future valuations:
| Current | 3.98 | 39.65% |
|---|---|---|
| 2025 | 4.03 | 1.25% |
| 2026 | 3.90 | 3.13% |
| 2027 | 3.80 | 2.77% |
| 2028 | 3.62 | 4.62% |
| Current | 3.68 | 39.92% |
|---|---|---|
| 2025 | 3.73 | 1.24% |
| 2026 | 3.61 | 3.13% |
| 2027 | 3.51 | 2.77% |
| 2028 | 3.35 | 4.62% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2025 |
| Morgan Stanley |
Underweight
➜
Equal-Weight
|
Upgrade | Oct 22 2025 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 22 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 22 2025 |
| RBC Capital |
Underperform
➜
Underperform
|
Unchanged | Oct 22 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 15 2025 |
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Oct 09 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 22 2025 |
|
Upgrade
Morgan Stanley:
Underweight
➜
Equal-Weight
|
Oct 22 2025 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 22 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 22 2025 |
|
Unchanged
RBC Capital:
Underperform
➜
Underperform
|
Oct 22 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 15 2025 |
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Oct 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


